Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
The global Human Rho(D) Immune Globulin market was valued at US$ 35 million in 2023 and is anticipated to reach US$ 62 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
North American market for Human Rho(D) Immune Globulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Rho(D) Immune Globulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Rho(D) Immune Globulin include 小袇L 袙械hr褨ng, 骋谤褨蹿芯濒褧, Bayer, Kedrion Biopharma and Saol Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Rho(D) Immune Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rho(D) Immune Globulin.
Report Scope
The Human Rho(D) Immune Globulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rho(D) Immune Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rho(D) Immune Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
小袇L 袙械hr褨ng
骋谤褨蹿芯濒褧
Bayer
Kedrion Biopharma
Saol Therapeutics
Segment by Type
Vial
Prefilled Syringe
Segment by Application
Government Institution
Private Sector
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rho(D) Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rho(D) Immune Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Human Rho(D) Immune Globulin 麻豆原创 Overview
1.1 Product Overview and Scope of Human Rho(D) Immune Globulin
1.2 Human Rho(D) Immune Globulin Segment by Type
1.2.1 Global Human Rho(D) Immune Globulin 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Vial
1.2.3 Prefilled Syringe
1.3 Human Rho(D) Immune Globulin Segment by Application
1.3.1 Global Human Rho(D) Immune Globulin 麻豆原创 Value by Application: (2024-2030)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Others
1.4 Global Human Rho(D) Immune Globulin 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Human Rho(D) Immune Globulin Revenue 2019-2030
1.4.2 Global Human Rho(D) Immune Globulin Sales 2019-2030
1.4.3 Global Human Rho(D) Immune Globulin 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Rho(D) Immune Globulin 麻豆原创 Competition by Manufacturers
2.1 Global Human Rho(D) Immune Globulin Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Human Rho(D) Immune Globulin Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Human Rho(D) Immune Globulin Average Price by Manufacturers (2019-2024)
2.4 Global Human Rho(D) Immune Globulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Rho(D) Immune Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rho(D) Immune Globulin, Product Type & Application
2.7 Human Rho(D) Immune Globulin 麻豆原创 Competitive Situation and Trends
2.7.1 Human Rho(D) Immune Globulin 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Rho(D) Immune Globulin Players 麻豆原创 Share by Revenue
2.7.3 Global Human Rho(D) Immune Globulin 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Rho(D) Immune Globulin Retrospective 麻豆原创 Scenario by Region
3.1 Global Human Rho(D) Immune Globulin 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Rho(D) Immune Globulin Global Human Rho(D) Immune Globulin Sales by Region: 2019-2030
3.2.1 Global Human Rho(D) Immune Globulin Sales by Region: 2019-2024
3.2.2 Global Human Rho(D) Immune Globulin Sales by Region: 2025-2030
3.3 Global Human Rho(D) Immune Globulin Global Human Rho(D) Immune Globulin Revenue by Region: 2019-2030
3.3.1 Global Human Rho(D) Immune Globulin Revenue by Region: 2019-2024
3.3.2 Global Human Rho(D) Immune Globulin Revenue by Region: 2025-2030
3.4 North America Human Rho(D) Immune Globulin 麻豆原创 Facts & Figures by Country
3.4.1 North America Human Rho(D) Immune Globulin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Rho(D) Immune Globulin Sales by Country (2019-2030)
3.4.3 North America Human Rho(D) Immune Globulin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Rho(D) Immune Globulin 麻豆原创 Facts & Figures by Country
3.5.1 Europe Human Rho(D) Immune Globulin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Rho(D) Immune Globulin Sales by Country (2019-2030)
3.5.3 Europe Human Rho(D) Immune Globulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rho(D) Immune Globulin 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Human Rho(D) Immune Globulin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Rho(D) Immune Globulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Rho(D) Immune Globulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Rho(D) Immune Globulin 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Human Rho(D) Immune Globulin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Rho(D) Immune Globulin Sales by Country (2019-2030)
3.7.3 Latin America Human Rho(D) Immune Globulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rho(D) Immune Globulin 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Human Rho(D) Immune Globulin 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Rho(D) Immune Globulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Rho(D) Immune Globulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Rho(D) Immune Globulin Sales by Type (2019-2030)
4.1.1 Global Human Rho(D) Immune Globulin Sales by Type (2019-2024)
4.1.2 Global Human Rho(D) Immune Globulin Sales by Type (2025-2030)
4.1.3 Global Human Rho(D) Immune Globulin Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Human Rho(D) Immune Globulin Revenue by Type (2019-2030)
4.2.1 Global Human Rho(D) Immune Globulin Revenue by Type (2019-2024)
4.2.2 Global Human Rho(D) Immune Globulin Revenue by Type (2025-2030)
4.2.3 Global Human Rho(D) Immune Globulin Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Human Rho(D) Immune Globulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Rho(D) Immune Globulin Sales by Application (2019-2030)
5.1.1 Global Human Rho(D) Immune Globulin Sales by Application (2019-2024)
5.1.2 Global Human Rho(D) Immune Globulin Sales by Application (2025-2030)
5.1.3 Global Human Rho(D) Immune Globulin Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Human Rho(D) Immune Globulin Revenue by Application (2019-2030)
5.2.1 Global Human Rho(D) Immune Globulin Revenue by Application (2019-2024)
5.2.2 Global Human Rho(D) Immune Globulin Revenue by Application (2025-2030)
5.2.3 Global Human Rho(D) Immune Globulin Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Human Rho(D) Immune Globulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 小袇L 袙械hr褨ng
6.1.1 小袇L 袙械hr褨ng Corporation Information
6.1.2 小袇L 袙械hr褨ng Description and Business Overview
6.1.3 小袇L 袙械hr褨ng Human Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 小袇L 袙械hr褨ng Human Rho(D) Immune Globulin Product Portfolio
6.1.5 小袇L 袙械hr褨ng Recent Developments/Updates
6.2 骋谤褨蹿芯濒褧
6.2.1 骋谤褨蹿芯濒褧 Corporation Information
6.2.2 骋谤褨蹿芯濒褧 Description and Business Overview
6.2.3 骋谤褨蹿芯濒褧 Human Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 骋谤褨蹿芯濒褧 Human Rho(D) Immune Globulin Product Portfolio
6.2.5 骋谤褨蹿芯濒褧 Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Human Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Human Rho(D) Immune Globulin Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Kedrion Biopharma
6.4.1 Kedrion Biopharma Corporation Information
6.4.2 Kedrion Biopharma Description and Business Overview
6.4.3 Kedrion Biopharma Human Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kedrion Biopharma Human Rho(D) Immune Globulin Product Portfolio
6.4.5 Kedrion Biopharma Recent Developments/Updates
6.5 Saol Therapeutics
6.5.1 Saol Therapeutics Corporation Information
6.5.2 Saol Therapeutics Description and Business Overview
6.5.3 Saol Therapeutics Human Rho(D) Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Saol Therapeutics Human Rho(D) Immune Globulin Product Portfolio
6.5.5 Saol Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rho(D) Immune Globulin Industry Chain Analysis
7.2 Human Rho(D) Immune Globulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rho(D) Immune Globulin Production Mode & Process
7.4 Human Rho(D) Immune Globulin Sales and 麻豆原创ing
7.4.1 Human Rho(D) Immune Globulin Sales Channels
7.4.2 Human Rho(D) Immune Globulin Distributors
7.5 Human Rho(D) Immune Globulin Customers
8 Human Rho(D) Immune Globulin 麻豆原创 Dynamics
8.1 Human Rho(D) Immune Globulin Industry Trends
8.2 Human Rho(D) Immune Globulin 麻豆原创 Drivers
8.3 Human Rho(D) Immune Globulin 麻豆原创 Challenges
8.4 Human Rho(D) Immune Globulin 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
小袇L 袙械hr褨ng
骋谤褨蹿芯濒褧
Bayer
Kedrion Biopharma
Saol Therapeutics
听
听
*If Applicable.